- Filed
- Mar 13, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2025 · Feb 26, 2025 | 126.48M sh |
| Current Liabilities | FY 2025 · Jan 31, 2024 | $267.77M |
| Total Liabilities | FY 2025 · Jan 31, 2024 | $361.64M |
| Current Assets | FY 2025 · Jan 31, 2024 | $359.91M |
| Total Assets | FY 2025 · Jan 31, 2024 | $508.81M |
| Shares Diluted | FY 2025 · Jan 31, 2023 | 125.25M sh |
| Stock Repurchased | FY 2025 · Jan 31, 2023 | $77.25M |
| Capex | FY 2025 · Jan 31, 2023 | $6.19M |
| Operating Cash Flow | FY 2025 · Jan 31, 2023 | $17.85M |
| Cash And Equivalents | FY 2025 · Jan 31, 2023 | $190.21M |
| Eps Diluted | FY 2025 · Jan 31, 2023 | −$0.53 |
| Eps Basic | FY 2025 · Jan 31, 2023 | −$0.53 |
| Sga Expense | FY 2025 · Jan 31, 2023 | $79.34M |
| Rd Expense | FY 2025 · Jan 31, 2023 | $70.9M |
| Net Income | FY 2025 · Jan 31, 2023 | −$65.94M |
| Operating Income | FY 2025 · Jan 31, 2023 | −$64.83M |
| Gross Profit | FY 2025 · Jan 31, 2023 | $296.89M |
| Cost Of Revenue | FY 2025 · Jan 31, 2023 | $103.96M |
| Revenue | FY 2025 · Jan 31, 2023 | $400.85M |
| Stockholders Equity | FY 2025 · Jan 31, 2022 | $211.87M |